Table 4.
CSF | SERUM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Protein | unity | A | B | C | D | CTRL* | A | B | C | D | CTRL* |
Neuronal Injury Biomarkers | |||||||||||
T Tau | pg/mL | 2723.64 | 234.2 | 771.55 | 137.7 | 633.7 (531.2; 764.6) | |||||
P Tau 181 | pg/mL | 59.39 | 200 | 59.39 | 162 | 132.0 (106.5; 179.5) | |||||
Aβ-38 | pg/mL | 899.91 | 1437.11 | 1581.10 | 355.76 | 2209 (1840; 2509) | 9.39 | 48.60 | 2.48 | 7.82 | 7.226 (2.480; 22.50) |
Aβ-40 | pg/mL | 2390.24 | 2773.68 | 3364.22 | 688.51 | 4561 (4182; 5116) | 99.70 | 194.30 | 18.47 | 114.30 | 117.9 (108.0; 141.7) |
Aβ-42 | pg/mL | 240.80 | 221.54 | 400.92 | 52.01 | 618.3 (548.6; 735.0) | 8.60 | 6.66 | 1.69 | 7.60 | 7.98 (5.24; 9.55) |
Aβ Total | pg/mL | 3530.95 | 4432.32 | 5346.23 | 1096.29 | 7357 (6665; 8316) | 117.65 | 249.56 | 22.64 | 129.74 | 140.6 (121.7; 172.6) |
sAPPα | ng/mL | 4.04 | 27.80 (16.40; 35.15) | 20.59 | 23.21 (17.99; 30.67) | ||||||
sAPPβ | ng/mL | 3.27 | 35.75 (27.05; 43.35) | 1.34 | 2.569(1.782; 4.716) | ||||||
sAPPα/β | 1.24 | 0,7557 (0,6007; 0,8710) | 15.38 | 8.68(4.7 8;13.26) | |||||||
NFL | pg/mL | 33121.95 | 15957.32 | 2351.68 | 702.52 | 659.6 (538.8; 801.6) | |||||
MBP** | ng/mL | 10.9 | 2.98 | 1.43 | 0.65 | < 1.1 | |||||
Ferritin *** | ng/mL | 29.6 | 7.21 | 2.82 | 2.07 | 5 (3;7) | 649.64 | 211.41 | 132.83 | 117.50 | 12–300 |
Monocyte and macrophage activation biomarkers | |||||||||||
sCD14 | pg/mL | 1139105 | 219330.9 | 90751.61 | 47545.63 | 85250 (69540; 100000) | 1896669 | 1832895 | 1909590 | 933747 | 1.4370e+006 (1.3550e+006; 1.5490e+006) |
Neopterin | nmol/L | 188.94 | 39.82 | 8.66 | 7.14 | 4.985 (4.618;5.641) | |||||
β2M**** | mg/L | 15.5 | 2.07 | 6.57 | 1.38 | 1.3±0.5 | 3.77 | 2,22 | 2,57 | 2,19 | 0.9–3.0 |
median (IQR);
myelin basic protein (MBP) normal range (Greene et al, 2012);
Ferritin normal range (Petzold et al, 2002);
β 2M normal range (Caudie et al, 2005)